Antimicrobial Stewardship and Healthcare Epidemiology
Gonzalo Bearman, MD, MPH, FACP, Chair, Division of Infectious Diseases, Virginia Commonwealth
Loading view.
Friday Morning Conference Series
HIV Cure
Sarah Joseph, PhD, Assistant Professor, Microbiology and Immunology, and Guochun Jiang, PhD, Assistant Professor, Biochemistry and Biophysics
M. Abscessus and the Susceptible Host: Environment, Pathogenesis, Transmission and Therapeutic Considerations
Kenneth Olivier, MD, MPH, Professor of Pulmonary Disease and Critical Care Medicine, and Director of the UNC Bronchiectasis/NTM Care and Research Center
HIV Cure
Nancy Archin, PhD, Assistant Professor, Infectious Diseases
From HIV to COVID and Back: COVID-19 Vaccines in People Living With HIV
Nigel Garrett, MBBS, MRCP, MSc, PhD, Honorary Associate Professor in Public Health at the University of KwaZulu-Natal, and head of HIV Pathogenesis and Vaccine Research for Center for the AIDS Programme of Research in South Africa (CAPRISA).
Pharmacological Evaluation of Long-Acting Formulations for HIV and TB
Andrew Owen, BSS, MSc, PhD, FSB, Professor of Molecular and Clinical Pharmacology at the University of Liverpool, UK, and Director of the Centre of Excellence in Long-acting Therapeutics (CELT).
Reconceptualizing Antibiotic Therapy Taking Host-Pathogen Interaction into Consideration
Gauri Rao, Pharm.D., M.S., is an associate professor at the UNC Eshelman School of Pharmacy in the Division of Pharmacotherapy and Experimental Therapeutics.
STI/HIV Research Presentations
T32 trainees will present STI/HIV research presentations.
Bacteriophage Therapy: Is it a Feasible Approach for Treating Intracellular Nontuberculous Mycobacteria?
Miriam Braunstein, PhD, Professor of Microbiology and Immunology, member of the Institute for Global Health & Infectious Diseases
HIV Persistence
Mary F. Kearney, PhD, HIV Dynamics and Replication Program, NIH Cancer Center
Host-Pathogen Dynamics
Nihal Altan-Bonn, PhD, Senior Investigator, NIH Laboratory of Host-Pathogen Dynamics
Building a Fasciola Hepatica Research Program in the Highlands of Peru
Miguel M. Cabada, MD, MSc, Associate Professor at the Division of Infectious Diseases of University of Texas Medical Branch
HIV Prevention During Pregnancy and Breastfeeding: Towards a Status-Neutral Approach
Ben Chi, MD, MSc, Professor, Vice Chair of Research and Innovation, Department of Obstetrics and Gynecology, and member of the Institute for Global Health & Infectious Diseases.
A Community-Led Model to Improve PrEP Uptake and HBV/HCV Testing Among MSM in China
Weiming Tang, PhD, Research Associate Professor and Co-Director of UNC Project-China with the Institute for Global Health & Infectious Diseases
An HIV Cure In 10 Years? Update On Progress and Challenges
David Margolis, MD, is Sarah Graham Kenan Distinguished Professor of Medicine, Professor of Microbiology & Immunology, and Epidemiology, and Director of the UNC HIV Cure Center. His research group has a long history of translational HIV research: investigating basic molecular, virological, and immunological phenomenon, and leveraging insights to develop new interventions in HIV disease. He … Read more
Looking Back and Looking Forward
Marcia Hobbs, PhD, is a professor of medicine in the division of infectious diseases. She conducts translational research focused on non-viral sexually transmitted infections; the lab supports a variety of research projects aimed directly at diagnosis, treatment and prevention of sexually transmitted infections or the use of these infections as bio-markers in evaluating biomedical or … Read more
The Dark Side of the Microbiome
J. Victor Garcia, PhD, director of the International Center for the Advancement of Translational Science and Oliver Smithies Investigator Professor of Medicine, is interested in how human viruses cause human cancer, how HIV causes AIDS, how SARS-CoV-2 causes COVD-19 and why the immune system is not able to control viral infections. The working hypothesis of … Read more
Impacts of Ecology On RTS,S Malaria Vaccine Efficacy
Michael Emch, PhD, is W.R. Kenan, Jr. Distinguished Professor of Geography and Epidemiology. He is also a Fellow of the Carolina Population Center. His expertise is in infectious disease ecology, spatial epidemiology, neighborhood determinants of health, and geographic information science applications of public health. He leads the Spatial Health Research Group which conducts research that … Read more
Translating Cabotegravir PrEP From Clinical Trials to the Field: Upcoming Malawi Plans
Mina Hosseinipour, MD, MPH, is a professor of medicine and the scientific director of UNC Project-Malawi. She focuses on the management of HIV disease in developing countries including prevention, interactions with endemic diseases, treatment of opportunistic infections including malignancies and monitoring strategies for antiretroviral therapy in this setting. The evaluation of the use of antiretroviral … Read more
Tracking the Gut Microbial Ecosystem in Cancer: My Adventures in Microbiome Science
Tessa M. Andermann, MD, MPH, is focus on how intestinal microbiome-host interactions impact infectious complications and other outcomes in patients with hematologic malignancies. Her goal is to develop microbiome-targeted therapies for the prevention and treatment of infectious diseases in these and other immunocompromised patient populations.